Fluoroscopy and C-arm Market to Reach $2.7 Billion Through 2022

April 10, 2018

WELLESLEY, Mass., April 10, 2018–The growing importance of medical imaging in the global healthcare industry is helping to boost the market for fluoroscopes and C-arms, according to a report by BCC Research. Fluoroscopes and C-arms are medical imaging systems that are based on X-ray technology that can produce real-time dynamic images.

The global market is estimated to be worth $2.7 billion in 2022, reaching a compound annual growth rate (CAGR) of 3.8%, according to the report Fluoroscopy and C-arms: Technologies and Global Markets.

The market for cardiovascular applications is driven mainly by the growing number of interventional heart procedures, especially minimally invasive surgeries. The increasing dependence on advanced mobile C-arms for these cardiovascular applications has caused a positive impact on the market.

Major players within this market include GE Healthcare, Philips Healthcare, Siemens Healthineers, Shimadzu Scientific Instruments Inc., Toshiba Medical Systems Corp., and Ziehm Imaging Inc.

Research Highlights

  • The rising number of patients suffering from cancer and chronic pain conditions, along with the emergence of innovative clinical techniques for decreasing discomfort, has spurred the demand for fluoroscopy in pain management and trauma applications.
  • Clinical applications for gastrointestinal investigation are estimated to be the slowest moving segment. It is projected to decrease by a -7.9% CAGR through 2022, when it could be valued at $102.4 million.
  • Meanwhile, applications for pain management and trauma are estimated to be the fastest moving segment. It is projected to increase by a 5.7% CAGR through 2022, when it could be valued at $483.2 million.

“In the last decade, there have been several advancements in fluoroscopy equipment and C-arms such as the emergence of advanced post-processing software for reducing the amount of radiation exposure,” said Robert G. Hunter, BCC Research senior editor, healthcare. “However, exposure to X-ray radiation has been the major hindering factor in the growth of the global fluoroscopy market. Other hindering factors include budgetary constraints of healthcare facilities, global cutbacks in healthcare expenditures and a growing presence of other advanced cross-sectional imaging modalities such as CT and MRI imaging.”

Obesity Epidemic Presents Challenges for Market

Although the market expects measured growth through 2022, the medical imaging industry is being challenged by the worldwide obesity epidemic. Morbid obesity poses problems for the imaging field, as huge bodily circumference and thick fat layers present challenges where intraoperative fluoroscopy and increased radiation are needed to identify anatomical structures. Fluoroscopic systems manufacturers, the report notes, are increasingly targeting this niche by offering systems which can provide clear images of morbidly obese patients without the need increase radiation doses.

Editors/reporters requesting analyst interviews should contact steven.cumming@bccresearch.com.

Fluoroscopy and C-arms: Technologies and Global Markets( HLC148B )
Publish Date: Mar 2018    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.